Abstract LB468: Pharmacokinetics of ALETA-001, a CRUK first-in-human phase I/II trial in patients who have received anti-CD19 CAR T-cell therapy for B-cell malignancies
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Newcastle University, Cancer Research UK
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154691718
Cites:
Cited by:
Related to: